From: Intensivist coverage and critically ill COVID-19 patient outcomes: a population-based cohort study
Variable | OR (95% CI) | P-value |
---|---|---|
WHO clinical progression scale: 1 point | ||
Ā Intensivist group (vs non-intensivist group) | 0.80 (0.55, 1.28) | 0.375 |
WHO clinical progression scale: 2 points | ||
Ā Intensivist group (vs non-intensivist group) | 0.75 (0.60, 0.89) | <ā0.001 |
WHO clinical progression scale: 3 points | ||
Ā Intensivist group (vs non-intensivist group) | 0.73 (0.60, 0.87) | <ā0.001 |
WHO clinical progression scale: 4 points | ||
Ā Intensivist group (vs non-intensivist group) | 0.67 (0.45, 0.82) | <ā0.001 |
WHO clinical progression scale: 5 points | ||
Ā Intensivist group (vs non-intensivist group) | 0.92 (0.80, 1.18) | 0.218 |
WHO clinical progression scale: 6 points | ||
Ā Intensivist group (vs non-intensivist group) | 0.68 (0.47, 0.99) | 0.048 |
ARDS group | ||
Ā Intensivist group (vs non-intensivist group) | 0.64 (0.41, 0.98) | 0.042 |
Hospital level group A | ||
Ā Intensivist group (vs non-intensivist group) | 0.89 (0.59, 1.34) | 0.577 |
Hospital level group B | ||
Ā Intensivist group (vs non-intensivist group) | 0.60 (0.28, 1.25) | 0.170 |
Hospital level group C | ||
Ā Intensivist group (vs non-intensivist group) | 0.72 (0.59, 0.88) | 0.001 |
Hospital level group D | ||
Ā Intensivist group (vs non-intensivist group) | 0.55 (0.23, 1.35) | 0.191 |